Main Catalog

Found 81
Sort by
Home Study Programs
Member Free
Non-Member Free

Expanding the Managed Care Professional’s Digital Therapeutics IQ - Home Study

Contact Hours: 1.5. Digital therapeutics are expanding the boundaries of the types of therapies that health care decision-makers must be adept at evaluating.
Digital Health
Home Study Programs
Member Free
Non-Member Free

The Impact of Value-Based Care on Inflammatory Bowel Disease - Home Study

Contact Hours: 1.5. Inflammatory bowel disease (IBD) affects approximately 1.3 million U.S. adults and creates a heavy psychological burden for patients because symptoms can occur spontaneously.
IBD
Home Study Programs
Member Free
Non-Member Free

Opioid Use Disorder: Emerging Best Practices for Payer and Clinician Management of Patient Care - Home Study

Addressing opioid use disorder (OUD) is a top concern for public health improvement. It is important to keep up with current treatment options to optimally treat patients, and while treatments vary by patient, a collaborative team environment is necessary for holistic care management.
Opioid
Home Study Programs
Member Free
Non-Member $30.00

Experience and Lessons Learned in Biosimilar Uptake

Contact Hours: 1.5. Although biosimilars have been on the market for some time, payers continue to face many challenges in implementation.
Biosimilars
Home Study Programs
Member Free
Non-Member $30.00

Medical Oncology Drug Cost Trends and Innovative, Practical Payer Management Strategies

Contact Hours: 1.5. Medical oncology drugs represent 35 to 47% percent of total medical benefit drug spend.
Oncology
Home Study Programs
Member Free
Non-Member $30.00

Coverage and Reimbursement for High Cost Curative Therapeutics: Does a Solution Exist?

Contact Hours: 1.5. More and more, managed care organizations are straddling the line between making new, innovative therapies available to their patients and ensuring they can cover the costs of these therapies.
Drug Pricing
Home Study Programs
Member Free
Non-Member $30.00

Using Online Real-World Evidence Tools to Enhance Formulary Decision-Making

Contact Hours: 1.5. Evidence to determine comparative effectiveness and safety requires the use of real-world data (RWD) to create real-world evidence (RWE) that ultimately is used to inform policy decisions.
Real World Evidence
Home Study Programs
Member Free
Non-Member $30.00

Specialty Pharmaceuticals in Development

Contact Hours: 1.25. Over the last several years, approvals of specialty pharmaceuticals have far outpaced those of traditional drugs. It is anticipated that this trend will continue.
Specialty Pharmacy
Home Study Programs
Member Free
Non-Member $30.00

A Path Forward: Medicaid Accountable Care Organization Implementation

Contact Hours: 1.5. While a dozen states have implemented new Accountable Care Organization (ACO) Medicaid models, another 12 are in the planning phases.
Accountable Care Organization
Home Study Programs
Member Free
Non-Member $30.00

End of an Era: Lessons Learned from 2018 CMS Audits, and Prep for the Future

Contact Hours: 1.5. Ready for that upcoming 2019 audit? Do you know how to prepare? If your answer is no, join this session to hear how health plans prepare for their audits and address corrective actions, as lessons learned from the 2018 audit season are discussed.
CMS
Home Study Programs
Member Free
Non-Member $30.00

Federal and State Legislative and Regulatory Update

Contact Hours: 1.5. This must-attend session will bring you timely updates on the latest federal and state legislative and regulatory actions of interest to managed care and specialty pharmacy professionals.
Law
Home Study Programs
Member Free
Non-Member $30.00

A State Medicaid’s Experience Implementing an Oversight Program for Behavioral Health Medications in Publicly Insured Youth

Contact Hours: 1.5. Utilization of behavioral health medications in the pediatric population has increased in recent years, a trend that has generated major concern given the limited supporting evidence.
Patient Care
Home Study Programs
Member Free
Non-Member $30.00

The CAR-T Carve Out: Reevaluating CAR-T Reimbursement and Long Term Outcomes

Contact Hours: 1.5. The CAR-T treatment process is complex and involves a multidisciplinary team, with intense coordination between patients, treating providers, manufacturers and payers.
Hospital/Health Systems
Home Study Programs
Member Free
Non-Member $30.00

Visions of a US Value-Based Health Care System

Contact Hours: 1.25. Value—a word of great promise and ambiguity—continues to chisel and sculpt the national health care system at large.
Hospital/Health Systems
Home Study Programs
Member Free
Non-Member $30.00

Understanding MACRA and the Impact of Medication Use on Quality Payment Program Performance Measures

CPE 1.5 | 1.5 AMA PRA | Nurse 1.5 Contact Hours | As part of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), providers have two options to participate in Part B that will determine how they are reimbursed through the new Quality Payment Program— (APMs) or (MIPS).
Hospital/Health Systems
Home Study Programs
Member Free
Non-Member $30.00

The Present and Future of Oncology Care Management

Contact Hours: 1.25. Participants should claim continuing pharmacy education (CPE) credit for this home study activity, only if they have not claimed credit for the live activity presented at AMCP Annual Meeting 2017.
Oncology
Home Study Programs
Member Free
Non-Member $30.00

The New Era of Precision Medicine in Oncology

Contact Hours: 1.5. Advances in cancer genomics have paved the way for a new era of precision medicine in oncology.
Oncology
Home Study Programs
Member $15.00
Non-Member $30.00

The Current Status of Safe Harbor Protection for Rebates: Is the End Near?

Contact Hours: 1.25: The Department of Health and Human Services (HHS) Office of Inspector General recently introduced a sweeping proposal that would eliminate safe harbor protections in the Anti-Kickback Statute for rebates.
Rebates
Home Study Programs
Member $15.00
Non-Member $30.00

The Current State of Value-Based Contracting

Contact Hours 1.25. Value-based contracting (VBC) has shown significant promise as an emerging model that rewards value rather than volume in health care.
Value-Based Contracting
Home Study Programs
Member $15.00
Non-Member $30.00

The Copay Card Conundrum: Examining the Usage, Regulation, and Management of Direct-to-Consumer Funding Programs

Contact Hours: 1.25. Drug manufacturer copay cards and coupons have been facing increasing criticism and scrutiny by legislators at the federal and state level, as well as by health plan payers, pharmacy benefit managers (PBMs) and employer groups.
Copay Cards
Home Study Programs
Member Free
Non-Member $30.00

The Basics of Mobile Health (mHealth) and Its Potential Impact

Contact Hours: 1.25. Participants should claim continuing pharmacy education (CPE) credit for this home study activity, only if they have not claimed credit for the live activity presented at AMCP Annual Meeting 2017.
Health IT
Home Study Programs
Member Free
Non-Member $30.00

Tackling the Opioid Epidemic and Addiction Treatment: A Managed Care Approach

Contact Hours: 1.25. Participants should claim continuing pharmacy education (CPE) credit for this home study activity, only if they have not claimed credit for the live activity presented at AMCP Annual Meeting 2017.
Opioid
Home Study Programs
Member $15.00
Non-Member $30.00

Strategies for Staying Ahead of Specialty Drug Trends: Focus on the Medical Pharmacy Benefit

Contact Hours 1.25. For the tenth consecutive year, specialty pharmaceutical growth has far exceeded that of traditional drugs.
Medical Pharmacy Benefit
Home Study Programs
Member Free
Non-Member $30.00

Spotlight on the Oncology Pipeline

CPE 1.5 | 1.5 AMA PRA | Nurse 1.5 Contact Hours | With the recent emphasis and success of immune checkpoint inhibitors for the treatment of various tumor types, it is tempting to assume that the oncology pipeline exclusively focuses on immunotherapies.
Oncology
Home Study Programs
Member Free
Non-Member $30.00

Specialty Pharmaceuticals in Development 2018

Contact Hours: 1.25. Over the last several years, approvals of specialty pharmaceuticals have far outpaced those of traditional drugs. It is anticipated that this trend will continue.
Specialty Pharmacy